Inside Reproductive Health Podcast

Restorative Reproductive Medicine isn't just a rebranding. It's a legal and legislative strategy aimed at IVF. And it's gaining ground.
A surprising number of fertility doctors have asked IRH to cover this topic, so we brought in the right person: Matt Maruca, Inception Fertility's chief legal counsel for seven years and a key figure in the Fertility Providers Alliance.
We dive into:
How Southern States approached IVF-hostile legislation in 2026

What tort reform could look like for IVF providers 

The donor-conceived community's growing influence on policy

What legislation the FPA is actively working to advance

How you can get involved, even if you don't work for Prelude or Inception

Is private practice making a comeback? More importantly, should it?
After five years at UCSF, Dr. Thalia Segal left academic medicine to launch Collab Fertility in one of the most competitive fertility markets in the country.
And she did it with no private equity and no venture capital.
Just a vision for building the kind of practice she believes both physicians and patients deserve.
We dive into:
Why some fertility physicians are reconsidering private equity-backed practices

Why Dr. Segal believes REIs should have greater oversight of the IVF lab

The financial realities of running a 300-cycle practice (without outside investors)

How she’s growing Collab Fertility and recruiting the next generation of REIs

Her 21 headcount payroll and the operational challenges she’s encountered along the way

3 fertility specialists have built massive digital brands with millions of collective followers.
In this episode, Dr. Aimee Eyvazzadeh (The Egg Whisperer), Dr. Roohi Jeelani (CEO of Onto Health), and Dr. Lucky Sekhon (Partner at RMA New York) discuss how they embody the same raw talent but leverage their public profiles for very different aims.
They dive into:
How fertility physicians build celebrity-level digital brands

The strategies behind maintaining a successful self-pay practice

Pursuing creative endeavors outside the clinic (like authoring a book)

Scaling a clinic group and building a tech-enabled OB/GYN referral network

Why Dr. Aimee added Juniper Genomics to her PGT roster

Game-changing innovation doesn’t happen by accident. 
It happens when the best minds in fertility are constantly testing, improving, and challenging what’s possible. 
We dive into this notion with Dr. Rita Vassena, Medical Director of Fertility at CooperSurgical. She spends her time visiting high-performing IVF labs around the world, identifying the technologies, processes, and ideas that are shaping the future of reproductive medicine. 
We discuss: 
What it will take to double IVF cycle output in the next five years 

How vitrification can be performed up to 90% faster 

CooperSurgical’s rapid blastocyst warming technology 

Emerging concepts that could reshape fertility treatment 

What leading lab directors are doing to maximize workflows and IVF supplies 

The next generation of fertility care is already taking shape - get a glimpse of what may be coming next.

Is PGT as we know it coming to an end?
Drs. Arlene Morales, Holly Mehr & Drew Tortoriello discuss what they see as the next evolution of PGT and why whole genome sequencing could reshape the future of embryo testing.
They dive into:
Why all PGT could include whole genome sequencing within five years

Concerns about PGT-P and direct-to-consumer marketing

What they want to hear from ASRM and other professional societies about genomics

What should be included in a large randomized controlled trial on PGT

Why they are cautiously optimistic about Juniper Genomics (And what makes PGT-G different)